Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.

Smyth LM, Piha-Paul SA, Won HH, Schram AM, Saura C, Loi S, Lu J, Shapiro GI, Juric D, Mayer IA, Arteaga CL, de la Fuente MI, Brufksy AM, Spanggaard I, Mau-Sorensen M, Arnedos M, Moreno V, Boni V, Sohn J, Schwartzberg LS, Gonzalez-Farre X, Cervantes A, Bidard FC, Gorelick AN, Lanman RB, Nagy RJ, Ulaner GA, Chandarlapaty S, Jhaveri K, Gavrila EI, Zimel C, Selcuklu SD, Melcer M, Samoila A, Cai Y, Scaltriti M, Mann G, Xu F, Eli LD, Dujka M, Lalani AS, Bryce R, Baselga J, Taylor BS, Solit DB, Meric-Bernstam F, Hyman DM.

Cancer Discov. 2019 Dec 5. pii: CD-19-0966. doi: 10.1158/2159-8290.CD-19-0966. [Epub ahead of print]

PMID:
31806627
2.

Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors.

Vasan N, Razavi P, Johnson JL, Shao H, Shah H, Antoine A, Ladewig E, Gorelick A, Lin TY, Toska E, Xu G, Kazmi A, Chang MT, Taylor BS, Dickler MN, Jhaveri K, Chandarlapaty S, Rabadan R, Reznik E, Smith ML, Sebra R, Schimmoller F, Wilson TR, Friedman LS, Cantley LC, Scaltriti M, Baselga J.

Science. 2019 Nov 8;366(6466):714-723. doi: 10.1126/science.aaw9032.

PMID:
31699932
3.

Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis.

Taylor J, Sendino M, Gorelick AN, Pastore A, Chang MT, Penson AV, Gavrila EI, Stewart C, Melnik EM, Herrejon Chavez F, Bitner L, Yoshimi A, Lee SC, Inoue D, Liu B, Zhang XJ, Mato AR, Dogan A, Kharas MG, Chen Y, Wang D, Soni RK, Hendrickson RC, Prieto G, Rodriguez JA, Taylor BS, Abdel-Wahab O.

Cancer Discov. 2019 Oct;9(10):1452-1467. doi: 10.1158/2159-8290.CD-19-0298. Epub 2019 Jul 8.

PMID:
31285298
4.

V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer.

Gao Y, Maria A, Na N, da Cruz Paula A, Gorelick AN, Hechtman JF, Carson J, Lefkowitz RA, Weigelt B, Taylor BS, Zhao H, Reis-Filho JS, de Stanchina E, Rosen N, Yao Z, Yaeger R.

Cancer Discov. 2019 Sep;9(9):1182-1191. doi: 10.1158/2159-8290.CD-19-0356. Epub 2019 Jun 21.

PMID:
31227518
5.

Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer.

Bielski CM, Donoghue MTA, Gadiya M, Hanrahan AJ, Won HH, Chang MT, Jonsson P, Penson AV, Gorelick A, Harris C, Schram AM, Syed A, Zehir A, Chapman PB, Hyman DM, Solit DB, Shannon K, Chandarlapaty S, Berger MF, Taylor BS.

Cancer Cell. 2018 Nov 12;34(5):852-862.e4. doi: 10.1016/j.ccell.2018.10.003. Epub 2018 Nov 1.

6.

Accelerating Discovery of Functional Mutant Alleles in Cancer.

Chang MT, Bhattarai TS, Schram AM, Bielski CM, Donoghue MTA, Jonsson P, Chakravarty D, Phillips S, Kandoth C, Penson A, Gorelick A, Shamu T, Patel S, Harris C, Gao J, Sumer SO, Kundra R, Razavi P, Li BT, Reales DN, Socci ND, Jayakumaran G, Zehir A, Benayed R, Arcila ME, Chandarlapaty S, Ladanyi M, Schultz N, Baselga J, Berger MF, Rosen N, Solit DB, Hyman DM, Taylor BS.

Cancer Discov. 2018 Feb;8(2):174-183. doi: 10.1158/2159-8290.CD-17-0321. Epub 2017 Dec 15.

7.

Glomus Tumor of the Esophagus: A Case Report and Review of the Literature.

Segura S, Mansoor S, Gorelick AB, Sieber S, El-Fanek H.

Conn Med. 2015 Feb;79(2):93-5. Review.

PMID:
26244207
8.

Patterns of ectopy leading to increased risk of fatal or near-fatal cardiac arrhythmia in patients with depressed left ventricular function after an acute myocardial infarction.

Lerma C, Gorelick A, Ghanem RN, Glass L, Huikuri HV.

Europace. 2013 Sep;15(9):1304-12. doi: 10.1093/europace/eus415. Epub 2013 Feb 5.

PMID:
23385051
9.

Excellence in stroke care: improving care in community hospitals.

Fedder W, Borsody M, Gorelick A, Ghilarducci D, Rymer M, Combes J, Meade A, Shephard TJ, Bushnell C.

Hosp Health Netw. 2012 Jul;86(7):49-9. No abstract available.

PMID:
22908798
10.

Fostering epilepsy self management: the perspectives of professionals.

Clark NM, Stoll S, Youatt EJ, Sweetman M, Derry R, Gorelick A.

Epilepsy Behav. 2010 Nov;19(3):255-63. doi: 10.1016/j.yebeh.2010.08.033.

PMID:
21145491
11.

Emergency department evaluation and management of stroke: acute assessment, stroke teams and care pathways.

Gorelick AR, Gorelick PB, Sloan EP.

Neurol Clin. 2008 Nov;26(4):923-42, viii. doi: 10.1016/j.ncl.2008.05.008. Review.

PMID:
19026897
12.

Botulinum toxin injection after biliary sphincterotomy.

Gorelick A, Barnett J, Chey W, Anderson M, Elta G.

Endoscopy. 2004 Feb;36(2):170-3.

PMID:
14765315
13.

First cut, then blend: an electrocautery technique affecting bleeding at sphincterotomy.

Gorelick A, Cannon M, Barnett J, Chey W, Scheiman J, Elta G.

Endoscopy. 2001 Nov;33(11):976-80.

PMID:
11668407
14.

Unsedated small-caliber esophagogastroduodenoscopy (EGD): less expensive and less time-consuming than conventional EGD.

Gorelick AB, Inadomi JM, Barnett JL.

J Clin Gastroenterol. 2001 Sep;33(3):210-4.

PMID:
11500609
15.

Identification of patients with resectable pancreatic cancer: at what stage are we?

Gorelick AB, Scheiman JM, Fendrick AM.

Am J Gastroenterol. 1998 Oct;93(10):1995-6.

PMID:
9772077
16.

Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans.

Gorelick AB, Koshy SS, Hooper FG, Bennett TC, Chey WD, Hasler WL.

Am J Physiol. 1998 Sep;275(3):G460-6. doi: 10.1152/ajpgi.1998.275.3.G460.

PMID:
9724256
17.

Ontogeny of membrane cofactor protein: phenotypic divergence in the fetal heart.

Gorelick A, Oglesby T, Rashbaum W, Atkinson J, Buyon JP.

Lupus. 1995 Aug;4(4):293-6. Erratum in: Lupus 1995 Dec;4(6):499.

PMID:
8528226
18.

SCID-PANSS: two-tier diagnostic system for psychotic disorders.

Kay SR, Opler LA, Spitzer RL, Williams JB, Fiszbein A, Gorelick A.

Compr Psychiatry. 1991 Jul-Aug;32(4):355-61.

PMID:
1935026
19.

Discussion.

Gorelick AN.

Bacteriol Rev. 1966 Sep;30(3):644-5. No abstract available.

20.

Further studies on superinfection in experimental cavine brucellosis.

KELLY EH, GORELICK AN, SILVERMAN SJ, BRAUN W.

J Infect Dis. 1953 Sep-Oct;93(2):187-91. No abstract available.

PMID:
13109230
21.

Further studies on superinfection in experimental cavine brucellosis.

KELLY EH, GORELICK AN, SILVERMAN SJ, BRAUN W.

J Infect Dis. 1953 Sep-Oct;93(2):181-6. No abstract available.

PMID:
13109229
22.

Superinfection in experimental brucellosis of guinea pigs.

POLLACK AD, KELLY EH, GORELICK AN, BRAUN W, VICTOR J.

J Infect Dis. 1952 May-Jun;90(3):267-72. No abstract available.

PMID:
14938616
23.

Therapy of experimental brucellosis.

KELLY EH, GORELICK AN.

J Infect Dis. 1952 May-Jun;90(3):249-57. No abstract available.

PMID:
14938614
24.

Studies on the in vivo fate of Brucella variants with different virulence.

BRAUN W, GORELICK AN, KRAFT M, MEAD DD.

J Infect Dis. 1951 Nov-Dec;89(3):286-95. No abstract available.

PMID:
14888955
25.

The growth of bacteria in a charcoal-cellophane system.

GORELICK AN, MEAD DD, KELLY EH.

J Bacteriol. 1951 Apr;61(4):507-13. No abstract available.

Supplemental Content

Loading ...
Support Center